Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie A Ward

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Lancet. Healthy Longevity|February 16, 2026
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trialWalter P Abhayaratna, Christopher M Reid, Katherine L Webb, et al.
ERJ Open Research|February 18, 2025
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudyStephanie A Ward, Robyn L Woods, Matthew T Naughton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 2, 2021
Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free SurvivalJoanne Ryan, Sara Espinoza, Michael E Ernst, et al.
Respirology (Carlton, Vic.)|May 17, 2022
Sleep-disordered breathing was associated with lower health-related quality of life and cognitive function in a cross-sectional study of older adultsStephanie A Ward, Elsdon Storey, Danijela Gasevic, et al.
Investigative Ophthalmology & Visual Science|October 6, 2025
Development and Validation of Polygenic Scores for Retinal Vessel CalibersChenglong Yu, Nuwanthi Rupasinghe, Liubov Robman, et al.
Journal of General Internal Medicine|March 23, 2021
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older AdultsJessica E Lockery, Jonathan C Broder, Joanne Ryan, et al.
JAMA Internal Medicine|November 7, 2022
Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical TrialAnna L Barker, Renata Morello, Le Thi Phuong Thao, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 3, 2022
Combination of gait speed and grip strength to predict cognitive decline and dementiaSuzanne G Orchard, Galina Polekhina, Joanne Ryan, et al.
Neurology|March 28, 2020
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive declineJoanne Ryan, Elsdon Storey, Anne M Murray, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Lancet. Healthy Longevity|February 16, 2026
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trialWalter P Abhayaratna, Christopher M Reid, Katherine L Webb, et al.
ERJ Open Research|February 18, 2025
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudyStephanie A Ward, Robyn L Woods, Matthew T Naughton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 2, 2021
Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free SurvivalJoanne Ryan, Sara Espinoza, Michael E Ernst, et al.
Respirology (Carlton, Vic.)|May 17, 2022
Sleep-disordered breathing was associated with lower health-related quality of life and cognitive function in a cross-sectional study of older adultsStephanie A Ward, Elsdon Storey, Danijela Gasevic, et al.
Investigative Ophthalmology & Visual Science|October 6, 2025
Development and Validation of Polygenic Scores for Retinal Vessel CalibersChenglong Yu, Nuwanthi Rupasinghe, Liubov Robman, et al.
Journal of General Internal Medicine|March 23, 2021
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older AdultsJessica E Lockery, Jonathan C Broder, Joanne Ryan, et al.
JAMA Internal Medicine|November 7, 2022
Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical TrialAnna L Barker, Renata Morello, Le Thi Phuong Thao, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 3, 2022
Combination of gait speed and grip strength to predict cognitive decline and dementiaSuzanne G Orchard, Galina Polekhina, Joanne Ryan, et al.
Neurology|March 28, 2020
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive declineJoanne Ryan, Elsdon Storey, Anne M Murray, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
Pageof 6